China SAT-1 Foot-and-Mouth Outbreak
Analysis based on 9 articles · First reported Apr 03, 2026 · Last updated Apr 03, 2026
The outbreak of SAT-1 foot-and-mouth disease in China is expected to negatively impact China's livestock sector, potentially leading to initial drops in cattle prices followed by increases as herd numbers fall. The fast-tracking of vaccines by Zhongnong Weite Biotechnology Co., Ltd could offer some mitigation, but concerns remain about cross-border transmission from Russia and potential trade restrictions.
China is currently facing an outbreak of the SAT-1 serotype of foot-and-mouth disease in its northwest regions, specifically China — Gansu and China — Xinjiang, affecting over 6,229 cattle. This is the first time this African-endemic strain has been detected in China, and existing domestic vaccines are ineffective against it. In response, China has tightened border controls, initiated culling of affected animals, and disinfected areas. The China — Ministry of Agriculture (China) is overseeing these measures. Two new SAT-1 vaccines produced by Zhongnong Weite Biotechnology Co., Ltd have received emergency approval and are expected to be available soon. The outbreak raises concerns about potential cross-border transmission, particularly from Russia, which is also battling a cattle disease. Analysts warn of significant production losses and a high mortality rate in young animals if the disease is not controlled, further straining China's livestock sector already grappling with falling meat prices and weak consumer demand.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard